Breaking News

Tulex Completes NJ Development and Manufacturing Facility

cGMP facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dose

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Tulex Pharmaceuticals, a specialty pharmaceutical company located in Cranbury, NJ, has recently completed its new, multi-million-dollar, cGMP development and manufacturing facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dosage forms.   Tulex has two proprietary technologies that focus on bio-availability enhancement and delivering predesigned drug release profiles that can be tailored to meet specific customer requirements.   Tul...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters